Cefuroxime and Dextrose NDC 0264-3114

NDC codes

FDA NDC Directory

Product NDC (as listed)0264-3114Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00264-3114Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0264-3114-11	00264311411	24 CONTAINER in 1 CASE (0264-3114-11) / 50 mL in 1 CONTAINERMarketed from Feb 21, 2001

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cefuroxime and Dextrose
Generic name (nonproprietary): cefuroxime and dextrose
Active ingredients: Cefuroxime sodium — 1.5 g/50mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: B. Braun Medical Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 050780
Marketing start: Feb 21, 2001
Listing expires: Dec 31, 2026
Other FDA classes: Cephalosporins (Chemical structure)
Identifiers: Product ID 0264-3114_6874a295-7ec7-4822-9d04-4dd9932b4546SPL ID 6874a295-7ec7-4822-9d04-4dd9932b4546SPL set ID 07170ee3-1a24-424f-a2a2-00bc92e98f85RxCUI 1665444, 1665449UNII R8A7M9MY61
Pharmacologic class: Cephalosporin Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400264311411 followed by a unit qualifier and the quantity

Package 00264-3114-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 5, 2020.

Indications (excerpt from the label)

INDICATIONS AND USAGE Cefuroxime for Injection USP and Dextrose Injection USP is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases: Lower Respiratory Tract Infections, including pneumonia, caused by Streptococcus pneumoniae, Haemophilus influenzae (including ampicillin-resistant strains), Klebsiella spp., Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, and Escherichia coli . Urinary Tract Infections caused by Escherichia coli and Klebsiella spp. Skin and Skin-Structure Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 050780

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 050780
Product	Strength	Form · route	Labeler	Product NDC
Cefuroxime and Dextrose	Cefuroxime sodium 750 mg/50mL	Injection, SolutionIntravenous	B. Braun Medical Inc.	0264-3112